Background: The management of suicidal crisis remains a major issue for clinicians, driving the development of new strategies to improve suicide prevention. Methods: We conducted a randomized controlled trial comparing a 7-week acceptance and commitment therapy (ACT) versus relaxation group, as adjunct to treatment as usual for adult outpatients suffering from a current suicidal behavior disorder. The primary outcome was the rate of change in the Columbia Suicide Severity Rating Scale suicidal ideation subscore (adding severity and intensity subscores). Secondary outcomes were the rates of change for depressive symptomatology, psychological pain, anxiety, hopelessness, anger, quality of life, and therapeutic processes. Assessments were performed in the 2 weeks preceding the beginning of the treatment (pretreatment assessment), and within 1 week (posttherapy assessment) and 3 months (follow-up assessment) after therapy completion. Results: Forty adults were included and randomized. The rate of change in ACT for suicidal ideation at the posttherapy assessment was higher than in the relaxation group (β [SE] = –1.88 [0.34] vs. –0.79 [0.37], respectively; p = 0.03). ACT effectiveness remained stable at the 3-month follow-up. We found a similar pattern of change for depressive symptomatology and anxiety, psychological pain, hopelessness, anger, and quality of life. Therapeutic processes improved more in the ACT group than in the relaxation group. Treatment adherence was high in the ACT group, all participants reported satisfaction with the program. Conclusions: Through its effectiveness in reducing suicidal ideation and improving the clinical dimensions associated with suicidal risk in patients suffering from a suicidal behavior disorder, ACT could be developed as an adjunctive strategy in programs for suicide prevention.

1.
Jimenez-Trevino L, Saiz PA, Corcoran P, Garcia-Portilla MP, Buron P, Garrido M, Diaz-Mesa E, Al-Halabi S, Bobes J: The incidence of hospital-treated attempted suicide in Oviedo, Spain. Crisis 2012; 33: 46–53.
2.
Kessler RC, Berglund P, Borges G, Nock M, Wang PS: Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990–1992 to 2001–2003. JAMA 2005; 293: 2487–2495.
3.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 5 (DSM-5). Washington, American Psychiatric Association, 2013.
4.
Hayes SC, Luoma JB, Bond FW, Masuda A, Lillis J: Acceptance and commitment therapy: model, processes and outcomes. Behav Res Ther 2006; 44: 1–25.
5.
Hayes SC, Levin ME, Plumb-Vilardaga J, Villatte JL, Pistorello J: Acceptance and commitment therapy and contextual behavioral science: examining the progress of a distinctive model of behavioral and cognitive therapy. Behav Ther 2013 44: 180–198.
6.
Luoma JB, Villatte JL: Mindfulness in the treatment of suicidal individuals. Cogn Behav Pract 2012; 19: 265–276.
7.
Holmes EA, Crane C, Fennell MJ, Williams JM: Imagery about suicide in depression – “flash-forwards”? J Behav Ther Exp Psychiatry 2007; 38: 423–434.
8.
Pettit JW, Temple SR, Norton PJ, Yaroslavsky I, Grover KE, Morgan ST, Schatte DJ: Thought suppression and suicidal ideation: preliminary evidence in support of a robust association. Depress Anxiety 2009; 26: 758–763.
9.
Najmi S, Wegner DM, Nock MK: Thought suppression and self-injurious thoughts and behaviors. Behav Res Ther 2007; 45: 1957–1965.
10.
Roemer L, Borkovec TD: Effects of suppressing thoughts about emotional material. J Abnorm Psychol 1994; 103: 467–474.
11.
Walser RD, Garvert DW, Karlin BE, Trockel M, Ryu DM, Taylor CB: Effectiveness of acceptance and commitment therapy in treating depression and suicidal ideation in veterans. Behav Res Ther 2015; 74: 25–31.
12.
Barnhofer T, Crane C, Brennan K, Duggan DS, Crane RS, Eames C, Radford S, Silverton S, Fennell MJ, Williams JM: Mindfulness-based cognitive therapy (MBCT) reduces the association between depressive symptoms and suicidal cognitions in patients with a history of suicidal depression. J Consult Clin Psychol 2015; 83: 1013–1020.
13.
Ducasse D, Rene E, Beziat S, Guillaume S, Courtet P, Olie E: Acceptance and commitment therapy for management of suicidal patients: a pilot study. Psychother Psychosom 2014; 83: 374–376.
14.
Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, Currier GW, Melvin GA, Greenhill L, Shen S, Mann JJ: The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry 2011; 168: 1266–1277.
15.
Mann JJ: The neurobiology of suicide. Nat Med 1998; 4: 25–30.
16.
Polk KL, Schoendorff B: The Act Matrix: A New Approach to Building Psychological Flexibility across Settings and Populations. Oakland, New Harbinger Publications, 2014.
17.
Polk KL, Schoendorff B, Webster M, Olaz FO: The Essential Guide to the Act Matrix: A Step-by-Step Approach to Using the Act Matrix Model in Clinical Practice. Oakland, New Harbinger Publications, 2016.
18.
Bernstein DA, Borkovec TD, Hazlett-Stevens H: New Directions in Progressive Relaxation Training: A Guidebook for Helping Professionals. New York, Praeger, 2000.
19.
Monestès JL, Villatte M, Mouras H, Loas G, Bond F: Traduction et validation française du questionnaire d’acceptation et d’action (AAQ-II). Eur Rev Appl Psychol 2009; 59: 301–308.
20.
Dionne F, Balbinotti M, Gillanders D, Gagnon J, Monestès JL: Validation of the cognitive fusion questionnaire (CFQ) in a French-speaking population. World Conference XII of the Association for Behavioral and Contextual Science, Minneapolis, 2014.
21.
Kretsch M, Berghmans C, Tarquinio C, Strub L: Validation française d’une échelle de pleine conscience: la Philadelphia Mindfulness Scale (conference paper). 5e Congrès de Psychologie de la Santé de Langue Française, Rennes, 2009.
22.
Jermann F, Billieux J, Laroi F: Mindful Attention Awareness Scale (MAAS): psychometric properties of the French translation and exploration of its relations with emotion regulation strategies. Psychol Assess 2009; 21: 506–514.
23.
Fava GA, Guidi J, Rafanelli C, Rickels K: The clinical inadequacy of the placebo model and the development of an alternative conceptual framework. Psychother Psychosom 2017; 86: 332–340.
24.
Ducasse D, Holden RR, Boyer L, Artero S, Guillaume S, Calati R, Courtet P, Olie E: Psychological pain in suicidal behavior: a meta-analysis. J Clin Psychiatry 2017, Epub ahead of print.–
25.
De Leon J, Baca-García E, Blasco-Fontecilla H: From the serotonin model of suicide to a mental pain model of suicide. Psychother Psychosom 2015; 84: 323–329.
26.
Fava GA, Tomba E, Bech P: Clinical pharmacopsychology: conceptual foundations and emerging tasks. Psychother Psychosom 2017; 86: 134–140.
27.
Courtet P, Gottesman II, Jollant F, Gould TD: The neuroscience of suicidal behaviors: what can we expect from endophenotype strategies? Transl Psychiatry 2011; 1:e7.
28.
Hayes SC, Wilson KG, Gifford EV, Follette VM, Strosahl K: Experimental avoidance and behavioral disorders: a functional dimensional approach to diagnosis and treatment. J Consult Clin Psychol 1996; 64: 1152–1168.
29.
Harris R: Passez à l’act: pratique de la thérapie d’acceptation et d’engagement.Carrefour des psychothérapies. Bruxelles, De Boeck, 2012.
30.
Shneidman ES: Suicide as psychache. J Nerv Mental Dis 1993; 181: 145–147.
31.
Hepburn SR, Crane C, Barnhofer T, Duggan DS, Fennell MJ, Williams JM: Mindfulness-based cognitive therapy may reduce thought suppression in previously suicidal participants: findings from a preliminary study. Br J Clin Psychol 2009; 48: 209–215.
32.
Eisenberger NI: The pain of social disconnection: examining the shared neural underpinnings of physical and social pain. Nat Rev Neurosci 2012; 13: 421–434.
33.
Hann KEJ, McCracken LM: A systematic review of randomized controlled trials of acceptance and commitment therapy for adults with chronic pain: outcome domains, design quality, and efficacy. J Context Behav Sci 2014; 3: 217–227.
34.
McCracken LM, Morley S: The psychological flexibility model: a basis for integration and progress in psychological approaches to chronic pain management. J Pain 2014; 15: 221–234.
35.
Hughes LS, Clark J, Colclough JA, Dale E, McMillan D: Acceptance and commitment therapy (ACT) for chronic pain: a systematic review and meta-analyses. Clin J Pain 2017; 33: 552–568.
36.
Schütze R, Rees C, Smith A, Slater H, Campbell JM, O’Sullivan P: How can we best reduce pain catastrophizing in adults with chronic noncancer pain? A systematic review and meta-analysis. J Pain 2018; 19: 233–256.
37.
Rathod H, Ram D, Sundarmurthy H, Rathod S, John D: Headache disability, suicidality and pain catastrophization – are they related. J Clin Diagn Res 2016; 10:VC01–VC04.
38.
Serpa JG, Taylor SL, Tillisch K: Mindfulness-based stress reduction (MBSR) reduces anxiety, depression, and suicidal ideation in veterans. Med Care 2014; 52:S19–S24.
39.
Levinger S, Somer E, Holden RR: The importance of mental pain and physical dissociation in youth suicidality. J Trauma Dissoc 2015; 16: 322–339.
40.
Jollant F, Lawrence NL, Olie E, Guillaume S, Courtet P: The suicidal mind and brain: a review of neuropsychological and neuroimaging studies. World J Biol Psychiatry 2011; 12: 319–339.
41.
Richard-Devantoy S, Olie E, Guillaume S, Bechara A, Courtet P, Jollant F: Distinct alterations in value-based decision-making and cognitive control in suicide attempters: toward a dual neurocognitive model. J Affect Disord 2013; 151: 1120–1124.
42.
Pollock LR, Williams JM: Problem-solving in suicide attempters. Psychol Med 2004; 34: 163–167.
43.
Kashdan TB, McKnight PE: Commitment to a purpose in life: an antidote to the suffering by individuals with social anxiety disorder. Emotion 2013; 13: 1150–1159.
44.
Niemiec CP, Ryan RM, Deci EL: The path taken: consequences of attaining intrinsic and extrinsic aspirations in post-college life. J Res Pers 2009; 73: 291–306.
45.
Xie W, Li H, Luo X, Fu R, Ying X, Wang N, Yin Q, Zou Y, Cui Y, Wang X, Shi C: Anhedonia and pain avoidance in the suicidal mind: behavioral evidence for motivational manifestations of suicidal ideation in patients with major depressive disorder. J Clin Psychol 2014; 70: 681–692.
46.
Heisel MJ, Flett GL: Purpose in life, satisfaction with life, and suicide ideation in a clinical sample. J Psychopathol Behav Assess 2004; 26: 127–135.
47.
Reker GT: The purpose-in-life test in an inmate population: an empirical investigation. J Clin Psychol 1977; 33: 688–693.
48.
Lester D, Castromayor IJ, Icli T: Locus of control, depression, and suicidal ideation among American, Philippine, and Turkish students. J Soc Psychol 1991; 131: 447–449.
49.
Marco JH, Guillen V, Botella C: The buffer role of meaning in life in hopelessness in women with borderline personality disorders. Psychiatry Res 2017; 247: 120–124.
50.
Miranda R, Nolen-Hoeksema S: Brooding and reflection: rumination predicts suicidal ideation at 1-year follow-up in a community sample. Behav Res Ther 2007; 45: 3088–3095.
51.
Brown KW, Ryan RM: The benefits of being present: Mindfulness and its role in psychological well-being. J Consult Clin Psychol 2003; 84: 822–848.
52.
Edwards MJ, Holden RR: Coping, meaning in life, and suicidal manifestations: examining gender differences. J Clin Psychol 2001; 57: 1517–1534.
53.
Kleiman EM, Beaver JK: A meaningful life is worth living: meaning in life as a suicide resiliency factor. Psychiatry Res 2013; 210: 934–939.
54.
Kleftaras G, Psarra E: Meaning in life, psychological well-being and depressive symptomatology: a comparative study. Psychology 2012; 3: 337–345.
55.
Lahoz T, Hvid M, Wang AG: Preventing repetition of attempted suicide. III. The Amager project, 5-year follow-up of a randomized controlled trial. Nord J Psychiatry 2016; 70: 547–553.
56.
Jamison EC, Bol KA: Previous suicide attempt and its association with method used in a suicide death. Am J Prev Med 2016; 51:S226–S233.
57.
Lopez-Castroman J, Jaussent I, Gorwood P, Courtet P: Suicidal depressed patients respond less well to antidepressants in the short term. Depress Anxiety 2016; 33: 483–494.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.